Episode notes
In this episode of The Quarterly Briefing, we delve into the financial complexities and strategic shifts of Walgreens Boots Alliance, Inc. We analyze their 10K filing for fiscal year 2024 and the latest earnings call for fiscal year 2025. The discussion covers the company’s operating losses, the challenges facing their U.S. retail pharmacy and healthcare segments, along with their international operations. We explore Walgreens’ commitment to ESG principles, their financial strategies, workforce development, supply chain resilience, and R&D initiatives. The podcast also touches on evolving consumer behavior, brand strengthening, and how Walgreens is navigating intense industry competition. This episode provides a comprehensive overview of how Walgreens is adapting to a rapidly changing healthcare landscape.
00:00 Introduction to The Quar ...
Keywords
Quarterly BriefingQ3Earnings#FinancialAnalysisinvestorrelationsRetailWalgreensWBAAIFinance